305 related articles for article (PubMed ID: 16051585)
1. Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Cocchi S; Codeluppi M; Guaraldi G; Squillace N; Bedini A; Venturelli C; Esposito R
Scand J Infect Dis; 2005; 37(5):396-8. PubMed ID: 16051585
[TBL] [Abstract][Full Text] [Related]
2. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B is still the drug of choice for invasive aspergillosis.
Agarwal R; Singh N
Am J Respir Crit Care Med; 2006 Jul; 174(1):102; author reply 102-3. PubMed ID: 16793999
[No Abstract] [Full Text] [Related]
5. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
van 't Hek LG; Verweij PE; Weemaes CM; van Dalen R; Yntema JB; Meis JF
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1694-6. PubMed ID: 9603157
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Stratakos G; Zakynthinos S
Respiration; 2007; 74(6):609-10. PubMed ID: 18037812
[No Abstract] [Full Text] [Related]
8. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Chow L; Brown NE; Kunimoto D
Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856
[TBL] [Abstract][Full Text] [Related]
9. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Wingard JR; Herbrecht R; Mauskopf J; Schlamm HT; Marciniak A; Roberts CS
Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
[TBL] [Abstract][Full Text] [Related]
10. Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Can MF; Yagci G; Gorenek L; Tozkoparan E; Ozerhan I; Cetiner S
Surg Infect (Larchmt); 2008 Feb; 9(1):99-104. PubMed ID: 18363474
[TBL] [Abstract][Full Text] [Related]
11. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
de Sévaux RG; Kullberg BJ; Verweij PE; van de Nes JA; Meis JF; van der Meer JW
Clin Infect Dis; 1998 Apr; 26(4):996-7. PubMed ID: 9564492
[No Abstract] [Full Text] [Related]
12. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
15. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
16. [Four cases of pulmonary aspergilloma successfully treated with drug therapy].
Kawana A
Jpn J Antibiot; 2000 Feb; 53(2):91-100; discussion 100-2. PubMed ID: 10896541
[No Abstract] [Full Text] [Related]
17. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
18. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
Azzola A; Passweg JR; Habicht JM; Bubendorf L; Tamm M; Gratwohl A; Eich G
J Clin Microbiol; 2004 Oct; 42(10):4805-8. PubMed ID: 15472346
[TBL] [Abstract][Full Text] [Related]
19. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Manzoor NF; Azim S; Fadoo Z
J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
[TBL] [Abstract][Full Text] [Related]
20. [A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
Uçan ES; Avkan Oğuz V; Güngör O; Gülşen A; Uğural Sezak N; Tertemiz KC; Ceylan E; Kargi A; Balci P; Ada E; Sanli A
Tuberk Toraks; 2006; 54(1):75-9. PubMed ID: 16615023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
